Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

NCT00770653 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Dyslipidemias

Interventions

DRUG: Pioglitazone and Metformin
DRUG: Glimepiride and Metformin

Sponsor

Takeda